Delivery Order SPE2DB22D3301-SPE2DB25FX4BN
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,165.86 firm fixed price delivery order is for the procurement of 40,000 units of PROCRIT 40,000 units/mL vial. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.74 firm fixed-price delivery order is for the supply of 20,000 units/mL of the medication PROCRIT. The contract has an ultimate completion date of January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,427.82 firm-fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT, with a completion date of September 13, 2024. This award is not set aside for a specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The $6,774.37 firm fixed price delivery order is for the supply of 10,000 units of the drug PROCRIT 10,000 units/mL. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,288.54 firm-fixed-price delivery order is for the supply of 40,000 units of PROCRIT (Epoetin alfa) 40,000 units/mL vials. The contract has an ultimate completion date of August 14, 2024 and was awarded on August 13, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,580.10, is for the delivery of 40,000 units of the medication PROCRIT 40,000 units/mL. The contract has a firm fixed price pricing type and an ultimate completion date of January 11, 2022. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is the prime contractor for this award. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $9,477.16 and a completion date of June 25, 2025. Amerisourcebergen is delivering 20,000 units/mL of PROCRIT, a medication used to treat anemia, under a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROCRIT 40,000 UNITS/ML VIALML to the Defense Logistics Agency (DLA). The $5,947.54 firm fixed-price delivery order has a completion date of July 15, 2024. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. Under this single-award IDC, Amerisourcebergen provides a...
- This federal contract award is for the delivery of PROCRIT 10,000 UNITS/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,571.44. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 4, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FX4BNDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,026.26 firm fixed-price delivery order is for the supply of 40,000 units of PROCRIT 40,000 units/mL vials. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 10/21/24 |